logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
Cancer Chemotherapy and Pharmacology 封面图

Cancer Chemotherapy and Pharmacology

IF2.3
论文数242
被引数9031
期刊论文 242
发表时间
delete
Irinotecan induces intestinal atrophy and compromises duodenal motility and mucosal permeability: in vivo and in vitro evaluations伊立替康诱导肠萎缩并损害十二指肠运动和黏膜通透性：体内和体外评估
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-10-26
delete0
deleteOAAI
deleteNathalie Arendt; Tania Payo-Serafín; Hans Lennernäs; Femke Heindryckx; Markus Sjöblom
delete分享
delete收藏
Biological frailty and chemotherapy dose intensity independently predict survival in older adults with Stage II–III colon cancer生物脆弱性与化疗剂量强度独立预测晚期成人II-III期结直肠癌患者的生存情况
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-10-23
delete0
PREAI
deleteAhmet Burak Ağaoğlu; Ferhat Ekinci; Mustafa Şahbazlar; Atike Pinar Erdogan
delete分享
delete收藏
Successful treatment with BrECADD in a patient with Dubin-Johnson syndrome and classic Hodgkin lymphoma: a case report杜宾-约翰逊综合征合并经典型霍奇金淋巴瘤患者成功使用BrECADD治疗：病例报告
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-10-23
delete0
deleteOAAI
deleteHishan Tharmaseelan; Christian Peter Jaworek; Peter Borchmann; Conrad-Amadeus Voltin; Martin Galler; Gareth J. Veal; Louisa Lepkes; Björn Reusch; Clara Velmans; Christian Netzer; Wenyu Yang; Uwe Fuhr; Shelby Barnett
delete分享
delete收藏
Protective effect of N-acetylcysteine on oxaliplatin-induced peripheral neuropathy in colorectal cancer: a randomized controlled trialN-乙酰半胱氨酸对奥沙利铂诱导的结直肠癌周围神经病变的保护作用：一项随机对照试验
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-10-23
delete0
PREAI
deleteZeyad K. Hegazy; Sahar K. Tawfik; Nehal M. Elmashad
delete分享
delete收藏
Translational applications and clinical utility of organoids in ovarian cancer: a systematic review类器官在卵巢癌中的转化应用与临床价值：一项系统综述
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-10-22
delete0
PREAI
deleteReem ALzahrani; Maha Ali Alghadmi
delete分享
delete收藏
Longitudinal plasma phosphorylated neurofilament-heavy chain levels in oxaliplatin-induced peripheral neuropathy: a prospective multi-institutional exploratory study奥沙利铂诱导的周围神经病变中纵向血浆磷酸化神经丝重链水平：一项前瞻性多中心探索性研究
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-10-14
delete0
deleteOAAI
deleteYoshiharu Motoo; Katsunori Shinozaki; Masatomo Miura; Tsuyoshi Takagi; Shingo Ito; Naohisa Yoshida; Yoshinori Munemoto; Akihito Tsuji
delete分享
delete收藏
Research and development of a multi-target HER2 inhibitor (CPD 1) and its mechanism and application in combating HER2-positive breast cancer多靶点HER2抑制剂（CPD 1）的研发及其在对抗HER2阳性乳腺癌中的机制与应用
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-10-12
delete0
PREAI
deleteJianchao Pan; Wenqing Zhang; Xiang Yang
delete分享
delete收藏
Antibody–drug conjugates in lung cancer: clinical development, therapeutic advances, and emerging challenges抗体偶联药物在肺癌中的应用：临床开发、治疗进展及新兴挑战
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-10-12
delete0
deleteOAAI
deleteYilin Zhao; Xiaoran Ma; Xiaozhen Liu; Li Yan
delete分享
delete收藏
Risk factors for immune-related adverse events associated with pembrolizumab in patients with solid tumors实体瘤患者接受帕博利珠单抗治疗相关免疫相关不良事件的风险因素
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-10-09
delete0
PREAI
deleteFarah Shkakhwa; Farah Basbous; Dalia Shakhatreh; Kamal Al-Rabi; Nour Faqeer
delete分享
delete收藏
Pharmacological targeting of xCT/system Xc− to modulate temozolomide sensitivity in glioma and glioblastoma preclinical models: a focused systematic review靶向xCT/system Xc−系统以调节替莫唑胺在胶质瘤和胶质母细胞瘤预临床模型中的敏感性：一项聚焦的系统综述
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-10-09
delete0
deleteOAAI
deleteSufyan Elhashani; Mohamed Elkawafi; Abdalmanam El Shekhi; Sanad Elrishe; Mahmoud A. Aloriby
delete分享
delete收藏
PROTACs in personalized and precision medicine: transforming targeted therapy with advances in selectivity and patient stratificationPROTACs在个性化与精准医学中的应用：通过选择性和患者分层技术的进步转化靶向治疗
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-10-09
delete0
PREAI
deleteSanket Nagmoti; Eshita Kadam; Nikhil Sakle; Harshad Kapare; Pawan N. Karwa
delete分享
delete收藏
Beyond gastric acid: pharmacologic modulation of the tumor microenvironment by vonoprazan and its drug-interaction implications for chemotherapy and immunotherapy超越胃酸：沃诺拉赞对肿瘤微环境的药理调控及其对化疗和免疫治疗的药物相互作用影响
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-10-09
delete0
PREAI
deleteGhassan Sonji; Nada Sonji; Afaf El Katerji
delete分享
delete收藏
Continuous infusion of granulocyte colony-stimulating factor is associated with an advantage in neutrophil recovery in pediatric oncologic disorders粒细胞集落刺激因子持续输注与儿科肿瘤性疾病中中性粒细胞恢复优势相关
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-10-03
delete0
deleteOAAI
deleteYi-Lun Wang; Tsung-Yen Chang; Shih-Hsiang Chen; Yi-Wen Hsiao; Yu-Chuan Wen; Tang-Her Jaing
delete分享
delete收藏
Association of androgen deprivation therapy and acute kidney injury in patients with prostate cancer: a systematic review and meta-analysis of 72,980 patients雄激素剥夺疗法与前列腺癌患者急性肾损伤的关联：一项包含72,980例患者的系统评价和荟萃分析
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-09-24
delete0
PREAI
deleteIago Zang Pires; Alexandre Yamada Fujimura; Marília Oberto da Silva Gobbo; Renan Yuji Ura Sudo; Tanize Louize Milbradt; Nilson Marquardt Filho; Gustavo Franco Carvalhal
delete分享
delete收藏
Crossing the toxicity threshold: a repeated landmark analysis of early toxicities and treatment modification during first-line CDK4/6 inhibitor therapy跨越毒性阈值：一线CDK4/6抑制剂治疗期间早期毒性和治疗调整的重复里程碑分析
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-09-24
delete0
PREAI
deleteTuğba Önder; Öztürk Ateş; Mehmet Emin Yılmaz; Ayşe Ocak Duran
delete分享
delete收藏
Population pharmacokinetic analysis of pirtobrutinib, a non-covalent BTK inhibitor, in patients with hematological malignancies from the Phase 1/2 BRUIN study吡鲁替尼（pirtobrutinib）在血液系统恶性肿瘤患者中的群体药代动力学分析，基于BRUIN研究（I/II期）
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-09-24
delete0
deleteOAAI
deleteRobert Bell; Lisa M O’Brien; Eunice Yuen; Dan Liu; Sonya C. Chapman
delete分享
delete收藏
Correction: Evaluation of QTc interval prolongation in patients with advanced clear cell renal cell carcinoma treated with first line sunitinib更正：接受一线舒尼替尼治疗的晚期透明细胞肾细胞癌患者QTc间期延长的评估
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-09-19
delete0
deleteOAAI
deleteAgata Sałek-Zań; Mirosława Püsküllüoğlu; Agnieszka Stąpór; Justyna Jaworska; Agnieszka Pietruszka; Aleksandra Grela-Wojewoda; Maciej Stąpór; Tomasz Banaś
delete分享
delete收藏
Main pulmonary artery enlargement during bevacizumab therapy in KRAS-mutant metastatic colon cancerKRAS突变转移性结肠癌患者接受贝伐珠单抗治疗期间的主肺动脉扩张
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-09-17
delete0
PREAI
deleteMehmet Fatih Ozbay; Fikret Atlım; Sertac Vurgun; Mehmet Hunur; Ayse Keven; Eren Sahin; Sema Sezgin Göksu; Mustafa Karaca
delete分享
delete收藏
Targeting ALDH2 with Alda-1 to reverse cisplatin resistance in lung adenocarcinoma使用Alda-1靶向ALDH2以逆转肺腺癌顺铂耐药性
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-09-17
delete0
PREAI
deleteMeidong Zhou; Fengjuan Tang; Zhiling Qu; Nan Luo; Sailong Ma; Xizhen Xu
delete分享
delete收藏
Modulating PI3K/Akt/mTOR-driven autophagy in liver cancer. The role of phytochemicals调节PI3K/Akt/mTOR驱动的肝癌自噬：植物化学物的作用
deleteCancer Chemotherapy and Pharmacology
IF2.3
delete2026-09-17
delete0
PREAI
deletePoonam Lal; Jitendra Patel
delete分享
delete收藏